Marker Therapeutics Inc.

1.94
0.56 (40.58%)
At close: Mar 05, 2025, 2:36 PM

Marker Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Net Income -14.05M -29.93M -41.88M -28.71M -21.43M -147.96M -10.98M -2.46M -34.07M -30.88M -5.53M -5.86M -2.03M -5.09M -4.46M -2.2M -3.89M -1.3M -985.6K -2.68M -5.78M -2.28M -379.86K -1.29M -1.13M
Depreciation & Amortization n/a 3.68M 3.16M 1.08M 286.58K n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.74K 7.48K 5.97K 6.37K 71.51K 37.45K 42.37K 40.89K n/a 20.64K 17.7K
Stock-Based Compensation 858.27K 3.3M 5.96M 5.23M 5.36M 16.35M 2.74M 1.56M 1.71M 1.39M 132.09K 2.44M 1.26M 2.29M 2.53M 234.17K 964.22K n/a n/a 2.73M n/a n/a n/a n/a n/a
Other Working Capital 861.11K -1.51M 1.33M -649.12K -1.52M -198.74K 19K -1.35K 13.7K -67.5K 100.38K 192.73K 120.89K 729.06K 693.2K 96K -12.51K -261.08K -162.89K 1.18M 402.11K 206.81K 138.98K -451.65K -17.63K
Other Non-Cash Items -6.1M -252.69K 7.15M -31K -18K 116.08M -497.87K -5.87M 27.91M 27.52M 2.12M -372.76K -597.68K 1.15M 1.07M 754.54K 2.3M 370.21K -90.73K 148.9K 2.74M 630.27K 243.26K 843.11K 284.27K
Deferred Income Tax n/a n/a -7.15M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -955.66K n/a -964.22K n/a n/a -2.73M n/a n/a n/a n/a n/a
Change in Working Capital 2.85M -5.81M 5.47M 3.57M -2.48M 1.04M 302.37K 256.24K 109.72K -212.7K 2.58M 2.23M 54.77K 729.06K 693.2K 485.32K 361.36K -258.06K -159.87K 1.28M 402.11K 206.81K 138.98K -451.65K 10.17K
Operating Cash Flow -16.44M -26.97M -27.28M -18.86M -18.28M -14.48M -8.44M -6.51M -4.34M -2.19M -694.58K -1.57M -1.31M -925.04K -1.12M -714.42K -1.23M -1.19M -1.16M -1.21M -2.59M -1.41M 2.38K -879.74K -815.18K
Capital Expenditures n/a -4.95M -3.13M -10.43M -374.98K -147.67K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -22.43K n/a -1.97K n/a -2.25K -5.82K n/a -2.86K -54.03K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 18.66M -4.95M -1.56M -6.79M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -22.43K -1.97K -1.97K -2.25K n/a 423.37K n/a n/a 17.27K
Investing Cash Flow 18.66M -4.95M -3.13M -10.43M -374.98K -147.67K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -22.43K -1.97K -1.97K -2.25K -2.25K 417.55K n/a -2.86K -36.76K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a -48K n/a 403K 740.2K 761.25K 724.53K 563.92K 485K 122K 583.23K 376.14K 60K 500K n/a 68.55K n/a 184.79K -83.49K
Common Stock Repurchased n/a n/a n/a n/a n/a -71.71K -310.49K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 90.48K n/a 3.09K 550K 816.48K 4.37M 619.62K 5.5M 8.31M n/a -30.87K 55.95K 128.6K 243.21K 77.17K 365.87K 277.61K n/a -206.65K 174.04K 44.21K -12.69K -2.38K n/a n/a
Financial Cash Flow 1.11M 202.13K 52.56M 6.74M 816.48K 71.25M 5.72M 7.78M 10.78M 2.28M 709.33K 1.37M 1.54M 807.13K 1.26M 547.87K 1.32M 1.22M 1.21M 1.22M 2.01M 1.63M -2.38K 807.79K 888.21K
Net Cash Flow 3.33M -31.72M 22.14M -22.55M -17.84M 56.62M -2.72M 1.27M 6.43M 93.36K 14.75K -199.56K 226.72K -117.92K 140.44K -166.55K 47.1K 64.19K 44.6K -7.8K -623.14K 631.03K n/a -43.58K 5.83K
Free Cash Flow -16.44M -31.92M -30.41M -29.29M -18.66M -14.63M -8.44M -6.51M -4.34M -2.19M -694.58K -1.57M -1.31M -925.04K -1.12M -714.42K -1.25M -1.19M -1.17M -1.21M -2.59M -1.41M 2.38K -882.6K -869.21K